MK8617 inhibits M1 macrophage polarization and inflammation via the HIF-1α/GYS1/UDPG/P2Y14 pathway

PeerJ. 2023 Jun 30:11:e15591. doi: 10.7717/peerj.15591. eCollection 2023.

Abstract

Background: Nonresolving inflammation is a major driver of disease and needs to be taken seriously. Hypoxia-inducible factor (HIF) is closely associated with inflammation. Hypoxia-inducible factor-prolyl hydroxylase inhibitors (HIF-PHIs), as stabilizers of HIF, have recently been reported to have the ability to block inflammation. We used MK8617, a novel HIF-PHI, to study its effect on macrophage inflammation and to explore its possible mechanisms.

Methods: Cell viability after MK8617 and lipopolysaccharide (LPS) addition was assessed by Cell Counting Kit-8 (CCK8) to find the appropriate drug concentration. MK8617 pretreated or unpretreated cells were then stimulated with LPS to induce macrophage polarization and inflammation. Inflammatory indicators in cells were assessed by real-time quantitative reverse-transcription polymerase chain reaction (qRT-PCR), western blot (WB) and immunofluorescence (IF). The level of uridine diphosphate glucose (UDPG) in the cell supernatant was measured by ELISA. Purinergic G protein-coupled receptor P2Y14, as well as hypoxia-inducible factor-1α (HIF-1α) and glycogen synthase 1 (GYS1) were detected by qRT-PCR and WB. After UDPG inhibition with glycogen phosphorylase inhibitor (GPI) or knockdown of HIF-1α and GYS1 with lentivirus, P2Y14 and inflammatory indexes of macrophages were detected by qRT-PCR and WB.

Results: MK8617 reduced LPS-induced release of pro-inflammatory factors as well as UDPG secretion and P2Y14 expression. UDPG upregulated P2Y14 and inflammatory indicators, while inhibition of UDPG suppressed LPS-induced inflammation. In addition, HIF-1α directly regulated GYS1, which encoded glycogen synthase, an enzyme that mediated the synthesis of glycogen by UDPG, thereby affecting UDPG secretion. Knockdown of HIF-1α and GYS1 disrupted the anti-inflammatory effect of MK8617.

Conclusions: Our study demonstrated the role of MK8617 in macrophage inflammation and revealed that its mechanism of action may be related to the HIF-1α/GYS1/UDPG/P2Y14 pathway, providing new therapeutic ideas for the study of inflammation.

Keywords: Glycogen synthase 1; Hypoxia-inducible factor-prolylhydroxylase inhibitor; Inflammation; Uridine diphosphate glucose/P2Y14 signaling pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Glycogen Synthase* / metabolism
  • Humans
  • Hypoxia / metabolism
  • Hypoxia-Inducible Factor 1, alpha Subunit / genetics
  • Inflammation / chemically induced
  • Lipopolysaccharides / pharmacology
  • Macrophages
  • Uridine Diphosphate Glucose* / metabolism

Substances

  • Uridine Diphosphate Glucose
  • Glycogen Synthase
  • Lipopolysaccharides
  • Hypoxia-Inducible Factor 1, alpha Subunit

Associated data

  • figshare/10.6084/m9.figshare.22494478.v1

Grants and funding

The work was supported by Scientific Project of Taizhou (No. TS201901) and Taizhou People’s Hospital Mandatory Project (No. ZL202012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.